AMICUS THERAPEUTICS, INC. (FOLD)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $323k
- Mar 2 · Unusual
- Form 4 sales
- 487
- On record
- Form 144 notices
- 53
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineNov 24 2025
Sold 76,158 shares at $10.16 ($774k)
Castelli Jeff, Chief Development Officer
10b5-1 planSold 14.8% of holdings ($5.2M position)439,318 shares leftFiling
- 2 Form 4 saleUnusualNov 26 +2 days
Sold 95,621 shares at $10.02 ($958k)
Rosenberg Ellen, Chief Legal Officer
10b5-1 planSold 15.8% of holdings ($6M position)507,710 shares left3.2x usual sizeFiling
- 3 Form 4 saleRoutineDec 1 +5 days
Sold 14,587 shares at $10.01 ($146k)
Campbell Bradley L, President and CEO
10b5-1 planSold 1.3% of holdings ($11.5M position)1.1M shares left1.9x usual sizeFiling
- 4 Form 4 saleRoutineDec 15 +14 days
Sold 25,643 shares at $11.00 ($282k)
Clark David Michael, Chief People Officer
10b5-1 planSold 8.6% of holdings ($3.3M position)271,332 shares left1.4x usual sizeFiling
- 5 Form 4 saleUnusualDec 15 same day
Sold 77,926 shares at $10.86 ($846k)
Campbell Bradley L, President and CEO
10b5-1 planSold 6.5% of holdings ($13.1M position)1.1M shares left10.4x usual sizeFiling
- 6 Form 4 saleRoutineDec 19 +4 days
Sold 25,642 shares at $14.17 ($363k)
Clark David Michael, Chief People Officer
10b5-1 planSold 9.5% of holdings ($3.8M position)245,690 shares left1x usual sizeFiling
- 7 Form 4 saleUnusualJan 20 +32 days
Sold 75,000 shares at $14.31 ($1.1M)
Campbell Bradley L, President and CEO
10b5-1 planSold 6.8% of holdings ($15.7M position)1M shares left10x usual sizeFiling
- 8 Form 4 saleUnusualMar 2 +41 days
Sold 22,500 shares at $14.35 ($323k)
Campbell Bradley L, President and CEO
10b5-1 planSold 2.2% of holdings ($14.7M position)998,680 shares left3x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (newest 400 of 540)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Campbell Bradley L | President and CEO | Form 4 sale | 22,500 | $323k | 2.2% | Unusual | SEC |
| Jan 20, 2026 | Campbell Bradley L | President and CEO | Form 4 sale | 75,000 | $1.1M | 6.8% | Unusual | SEC |
| Dec 19, 2025 | Clark David Michael | Chief People Officer | Form 4 sale | 25,642 | $363k | 9.5% | Routine | SEC |
| Dec 15, 2025 | Campbell Bradley L | President and CEO | Form 4 sale | 77,926 | $846k | 6.5% | Unusual | SEC |
| Dec 15, 2025 | Clark David Michael | Chief People Officer | Form 4 sale | 25,643 | $282k | 8.6% | Routine | SEC |
| Dec 1, 2025 | Campbell Bradley L | President and CEO | Form 4 sale | 14,587 | $146k | 1.3% | Routine | SEC |
| Nov 26, 2025 | Rosenberg Ellen | Chief Legal Officer | Form 4 sale | 95,621 | $958k | 15.8% | Unusual | SEC |
| Nov 24, 2025 | Castelli Jeff | Chief Development Officer | Form 4 sale | 76,158 | $774k | 14.8% | Routine | SEC |
| Nov 24, 2025 | Clark David Michael | Chief People Officer | Form 4 sale | 25,643 | $259k | 7.9% | Routine | SEC |
| Nov 24, 2025 | Campbell Bradley L | President and CEO | Form 4 sale | 14,587 | $146k | 1.3% | Routine | SEC |
| Nov 4, 2025 | Clark David Michael | Chief People Officer | Form 4 sale | 25,643 | $244k | 7.4% | Routine | SEC |
| Feb 19, 2025 | Campbell Bradley L | President and CEO | Form 4 sale | 400 | $4k | 0.0% | Routine | SEC |
| Dec 2, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 7,500 | $75k | 0.8% | Routine | SEC |
| Dec 2, 2024 | Campbell Bradley L | Director, Officer | Form 144 notice | 7,500 | $75k | Notice | SEC | |
| Nov 6, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 7,901 | $99k | 0.9% | Routine | SEC |
| Nov 1, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 7,500 | $86k | 0.8% | Routine | SEC |
| Oct 1, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 7,500 | $80k | 0.8% | Routine | SEC |
| Sep 3, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 7,500 | $88k | 0.8% | Routine | SEC |
| Aug 1, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 7,500 | $78k | 0.8% | Routine | SEC |
| Jul 5, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 6,100 | $61k | 0.7% | Routine | SEC |
| Jul 1, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 1,400 | $14k | 0.2% | Routine | SEC |
| Jun 3, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 7,500 | $75k | 0.8% | Routine | SEC |
| May 1, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 7,500 | $76k | 0.8% | Routine | SEC |
| Apr 1, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 7,500 | $88k | 0.8% | Routine | SEC |
| Mar 15, 2024 | Crowley John F | Director, Officer | Form 144 notice | 29,181 | $337k | Notice | SEC | |
| Mar 5, 2024 | Mcglynn Margaret G | Director | Form 4 sale | 15,000 | $200k | 20.2% | Routine | SEC |
| Mar 5, 2024 | Mcglynn Margaret G | Director | Form 144 notice | 7,500 | $101k | Notice | SEC | |
| Mar 4, 2024 | Mcglynn Margaret G | Director | Form 144 notice | 7,500 | $100k | Notice | SEC | |
| Mar 1, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 15,833 | $208k | 1.8% | Routine | SEC |
| Mar 1, 2024 | Crowley John F | Executive Chairman | Form 4 sale | 29,181 | $390k | 4.8% | Routine | SEC |
| Mar 1, 2024 | Campbell Bradley L | Director, Officer | Form 144 notice | 15,833 | $203k | Notice | SEC | |
| Mar 1, 2024 | Crowley John F | Director, Officer | Form 144 notice | 29,181 | $374k | Notice | SEC | |
| Feb 15, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 4,167 | $58k | 0.5% | Routine | SEC |
| Feb 15, 2024 | Clark David Michael | Chief People Officer | Form 4 sale | 4,427 | $62k | 1.7% | Routine | SEC |
| Feb 15, 2024 | Crowley John F | Executive Chairman | Form 4 sale | 31,614 | $437k | 4.3% | Unusual | SEC |
| Feb 15, 2024 | Crowley John F | Director, Officer | Form 144 notice | 31,614 | $417k | Notice | SEC | |
| Feb 15, 2024 | Campbell Bradley L | Director, Officer | Form 144 notice | 4,167 | $55k | Notice | SEC | |
| Feb 15, 2024 | Clark David Michael | Officer | Form 144 notice | 4,427 | $58k | Notice | SEC | |
| Feb 7, 2024 | Rosenberg Ellen | Chief Legal Officer | Form 4 sale | 30,000 | $390k | 7.5% | Routine | SEC |
| Feb 6, 2024 | Rosenberg Ellen | Officer | Form 144 notice | 30,000 | $381k | Notice | SEC | |
| Feb 1, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 15,833 | $199k | 1.8% | Routine | SEC |
| Feb 1, 2024 | Crowley John F | Executive Chairman | Form 4 sale | 31,614 | $399k | 4.0% | Unusual | SEC |
| Feb 1, 2024 | Campbell Bradley L | Director, Officer | Form 144 notice | 15,833 | $197k | Notice | SEC | |
| Feb 1, 2024 | Crowley John F | Director, Officer | Form 144 notice | 31,614 | $393k | Notice | SEC | |
| Jan 22, 2024 | Crowley John F | Executive Chairman | Form 4 sale | 55,327 | $684k | 6.6% | Unusual | SEC |
| Jan 22, 2024 | Crowley John F | Director, Officer | Form 144 notice | 55,327 | $666k | Notice | SEC | |
| Jan 16, 2024 | Crowley John F | Executive Chairman | Form 4 sale | 31,614 | $404k | 3.6% | Unusual | SEC |
| Jan 16, 2024 | Crowley John F | Director, Officer | Form 144 notice | 31,614 | $417k | Notice | SEC | |
| Jan 10, 2024 | Crowley John F | Executive Chairman | Form 4 sale | 31,614 | $432k | 3.5% | Unusual | SEC |
| Jan 10, 2024 | Crowley John F | Director, Officer | Form 144 notice | 31,614 | $432k | Notice | SEC | |
| Jan 9, 2024 | Prout Samantha | Officer | Form 144 notice | 1,337 | $19k | Notice | SEC | |
| Jan 9, 2024 | Clark David Michael | Officer | Form 144 notice | 1,384 | $19k | Notice | SEC | |
| Jan 9, 2024 | Clark David Michael | Chief People Officer | Form 4 sale | 10,110 | $142k | 3.7% | Routine | SEC |
| Jan 9, 2024 | Prout Samantha | Chief Accounting Officer | Form 4 sale | 32,104 | $449k | 28.4% | Routine | SEC |
| Jan 8, 2024 | Clark David Michael | Officer | Form 144 notice | 8,726 | $118k | Notice | SEC | |
| Jan 8, 2024 | Prout Samantha | Officer | Form 144 notice | 30,767 | $416k | Notice | SEC | |
| Jan 2, 2024 | Campbell Bradley L | President and CEO | Form 4 sale | 15,833 | $225k | 1.6% | Routine | SEC |
| Jan 2, 2024 | Rosenberg Ellen | Chief Legal Officer | Form 4 sale | 30,000 | $426k | 8.1% | Routine | SEC |
| Jan 2, 2024 | Rosenberg Ellen | Officer | Form 144 notice | 30,000 | $426k | Notice | SEC | |
| Jan 2, 2024 | Campbell Bradley L | Director, Officer | Form 144 notice | 15,833 | $225k | Notice | SEC | |
| Dec 28, 2023 | Castelli Jeff | Chief Development Officer | Form 4 sale | 17,421 | $253k | 4.9% | Routine | SEC |
| Dec 28, 2023 | Castelli Jeff | Officer | Form 144 notice | 1,575 | $23k | Notice | SEC | |
| Dec 27, 2023 | Rosenberg Ellen | Chief Legal Officer | Form 4 sale | 35,000 | $490k | 9.3% | Unusual | SEC |
| Dec 26, 2023 | Prout Samantha | Chief Accounting Officer | Form 4 sale | 7,659 | $107k | 5.9% | Routine | SEC |
| Dec 26, 2023 | Prout Samantha | Officer | Form 144 notice | 7,659 | $104k | Notice | SEC | |
| Dec 26, 2023 | Rosenberg Ellen | Officer | Form 144 notice | 35,000 | $476k | Notice | SEC | |
| Dec 20, 2023 | Castelli Jeff | Officer | Form 144 notice | 17,500 | $231k | Notice | SEC | |
| Dec 20, 2023 | Castelli Jeff | Chief Development Officer | Form 4 sale | 19,154 | $254k | 5.1% | Routine | SEC |
| Dec 19, 2023 | Castelli Jeff | Officer | Form 144 notice | 17,500 | $222k | Notice | SEC | |
| Dec 15, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,043 | $77k | 0.7% | Routine | SEC |
| Dec 15, 2023 | Crowley John F | Director, Officer | Form 144 notice | 6,043 | $75k | Notice | SEC | |
| Dec 1, 2023 | Campbell Bradley L | President and CEO | Form 4 sale | 11,702 | $130k | 1.5% | Routine | SEC |
| Dec 1, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,043 | $67k | 0.7% | Routine | SEC |
| Dec 1, 2023 | Crowley John F | Director, Officer | Form 144 notice | 6,043 | $67k | Notice | SEC | |
| Nov 15, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,043 | $66k | 0.7% | Routine | SEC |
| Nov 15, 2023 | Crowley John F | Director, Officer | Form 144 notice | 6,043 | $65k | Notice | SEC | |
| Nov 1, 2023 | Campbell Bradley L | President and CEO | Form 4 sale | 11,700 | $128k | 1.5% | Routine | SEC |
| Nov 1, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $66k | 0.7% | Routine | SEC |
| Nov 1, 2023 | Campbell Bradley L | Director, Officer | Form 144 notice | 23,402 | $257k | Notice | SEC | |
| Nov 1, 2023 | Crowley John F | Director, Officer | Form 144 notice | 6,044 | $66k | Notice | SEC | |
| Oct 16, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $63k | 0.7% | Routine | SEC |
| Oct 16, 2023 | Crowley John F | Director, Officer | Form 144 notice | 6,044 | $63k | Notice | SEC | |
| Oct 2, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $68k | 0.7% | Routine | SEC |
| Oct 2, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 11,700 | $131k | 1.5% | Routine | SEC |
| Oct 2, 2023 | Crowley John F | Director, Officer | Form 144 notice | 6,044 | $73k | Notice | SEC | |
| Oct 2, 2023 | Campbell Bradley L | Director, Officer | Form 144 notice | 11,700 | $142k | Notice | SEC | |
| Sep 15, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $79k | 0.7% | Routine | SEC |
| Sep 12, 2023 | Quimi Daphne | Officer | Form 144 notice | 9,709 | $129k | Notice | SEC | |
| Sep 11, 2023 | Quimi Daphne | Officer | Form 144 notice | 2,125 | $27k | Notice | SEC | |
| Sep 1, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $78k | 0.7% | Routine | SEC |
| Sep 1, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 18,093 | $235k | 2.2% | Routine | SEC |
| Sep 1, 2023 | Campbell Bradley L | Director, Officer | Form 144 notice | 18,093 | $232k | Notice | SEC | |
| Sep 1, 2023 | Crowley John F | Director, Officer | Form 144 notice | 12,088 | $155k | Notice | SEC | |
| Aug 15, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $79k | 0.6% | Routine | SEC |
| Aug 15, 2023 | Crowley John F | Officer | Form 144 notice | 6,044 | $80k | Notice | SEC | |
| Aug 9, 2023 | Prout Samantha | Chief Accounting Officer | Form 4 sale | 36,909 | $517k | 21.2% | Routine | SEC |
| Aug 9, 2023 | Prout Samantha | Officer | Form 144 notice | 36,909 | $512k | Notice | SEC | |
| Aug 1, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $81k | 0.6% | Routine | SEC |
| Aug 1, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 20,000 | $268k | 2.4% | Routine | SEC |
| Aug 1, 2023 | Campbell Bradley L | Director, Officer | Form 144 notice | 20,000 | $272k | Notice | SEC | |
| Aug 1, 2023 | Crowley John F | Officer | Form 144 notice | 6,044 | $82k | Notice | SEC | |
| Jul 17, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $81k | 0.6% | Routine | SEC |
| Jul 17, 2023 | Crowley John F | Officer | Form 144 notice | 6,044 | $81k | Notice | SEC | |
| Jul 13, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 8,300 | $104k | 1.0% | Routine | SEC |
| Jul 12, 2023 | Campbell Bradley L | Officer | Form 144 notice | 8,300 | $100k | Notice | SEC | |
| Jul 3, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $74k | 0.6% | Routine | SEC |
| Jul 3, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 11,700 | $144k | 1.4% | Routine | SEC |
| Jul 3, 2023 | Campbell Bradley L | Officer | Form 144 notice | 11,700 | $147k | Notice | SEC | |
| Jul 3, 2023 | Crowley John F | Officer | Form 144 notice | 6,044 | $76k | Notice | SEC | |
| Jun 15, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $79k | 0.6% | Routine | SEC |
| Jun 15, 2023 | Crowley John F | Officer | Form 144 notice | 6,044 | $80k | Notice | SEC | |
| Jun 6, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 8,300 | $104k | 1.0% | Routine | SEC |
| Jun 6, 2023 | Campbell Bradley L | Officer | Form 144 notice | 8,300 | $101k | Notice | SEC | |
| Jun 1, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $69k | 0.6% | Routine | SEC |
| Jun 1, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 11,700 | $133k | 1.4% | Routine | SEC |
| Jun 1, 2023 | Crowley John F | Officer | Form 144 notice | 6,044 | $68k | Notice | SEC | |
| Jun 1, 2023 | Campbell Bradley L | Officer | Form 144 notice | 11,700 | $132k | Notice | SEC | |
| May 15, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $68k | 0.6% | Routine | SEC |
| May 15, 2023 | Crowley John F | Officer | Form 144 notice | 6,044 | $68k | Notice | SEC | |
| May 1, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $71k | 0.6% | Routine | SEC |
| May 1, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 11,700 | $138k | 1.4% | Routine | SEC |
| May 1, 2023 | Campbell Bradley L | Officer | Form 144 notice | 11,700 | $135k | Notice | SEC | |
| May 1, 2023 | Crowley John F | Officer | Form 144 notice | 6,044 | $70k | Notice | SEC | |
| Apr 17, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $70k | 0.6% | Routine | SEC |
| Apr 3, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $68k | 0.6% | Routine | SEC |
| Apr 3, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 11,700 | $131k | 1.4% | Routine | SEC |
| Mar 17, 2023 | Raab Michael | Director | Form 4 sale | 4,408 | $50k | 6.8% | No plan | SEC |
| Mar 15, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $69k | 0.6% | Plan not stated | SEC |
| Mar 1, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $81k | 0.6% | Plan not stated | SEC |
| Mar 1, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 20,000 | $265k | 2.3% | Plan not stated | SEC |
| Feb 15, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 6,044 | $78k | 0.6% | Plan not stated | SEC |
| Feb 1, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 147,316 | $1.9M | 12.8% | Unusual | SEC |
| Feb 1, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 20,000 | $260k | 2.3% | Plan not stated | SEC |
| Jan 24, 2023 | Rosenberg Ellen | Chief Legal Officer | Form 4 sale | 31,839 | $424k | 8.7% | Plan not stated | SEC |
| Jan 18, 2023 | Clark David Michael | Chief People Officer | Form 4 sale | 7,382 | $100k | 3.0% | Plan not stated | SEC |
| Jan 18, 2023 | Quimi Daphne | Chief Financial Officer | Form 4 sale | 11,923 | $152k | 2.9% | Plan not stated | SEC |
| Jan 13, 2023 | Mcglynn Margaret G | Director | Form 4 sale | 15,000 | $195k | 22.8% | Plan not stated | SEC |
| Jan 9, 2023 | Crowley John F | Executive Chairman | Form 4 sale | 85,102 | $973k | 8.8% | Unusual | SEC |
| Jan 9, 2023 | Campbell Bradley L | President & CEO | Form 4 sale | 11,700 | $134k | 1.4% | Plan not stated | SEC |
| Jan 6, 2023 | Clark David Michael | Chief People Officer | Form 4 sale | 21,507 | $255k | 8.9% | Plan not stated | SEC |
| Jan 3, 2023 | Clark David Michael | Chief People Officer | Form 4 sale | 8,493 | $102k | 4.3% | Plan not stated | SEC |
| Dec 15, 2022 | Crowley John F | Executive Chairman | Form 4 sale | 10,468 | $127k | 1.3% | Plan not stated | SEC |
| Dec 1, 2022 | Crowley John F | Executive Chairman | Form 4 sale | 11,347 | $138k | 1.4% | Plan not stated | SEC |
| Dec 1, 2022 | Campbell Bradley L | President & CEO | Form 4 sale | 5,485 | $67k | 0.8% | Plan not stated | SEC |
| Nov 15, 2022 | Crowley John F | Executive Chairman | Form 4 sale | 10,468 | $122k | 1.3% | Plan not stated | SEC |
| Nov 1, 2022 | Crowley John F | Executive Chairman | Form 4 sale | 11,346 | $117k | 1.4% | Plan not stated | SEC |
| Nov 1, 2022 | Campbell Bradley L | President & CEO | Form 4 sale | 5,470 | $55k | 0.8% | Plan not stated | SEC |
| Oct 17, 2022 | Crowley John F | Executive Chairman | Form 4 sale | 10,468 | $114k | 1.2% | Plan not stated | SEC |
| Oct 3, 2022 | Crowley John F | Executive Chairman | Form 4 sale | 11,346 | $122k | 1.3% | Plan not stated | SEC |
| Oct 3, 2022 | Campbell Bradley L | President & CEO | Form 4 sale | 5,470 | $58k | 0.8% | Plan not stated | SEC |
| Sep 15, 2022 | Crowley John F | Executive Chairman | Form 4 sale | 10,468 | $112k | 1.2% | Plan not stated | SEC |
| Sep 1, 2022 | Quimi Daphne | Chief Financial Officer | Form 4 sale | 4,397 | $50k | 1.3% | Plan not stated | SEC |
| Sep 1, 2022 | Crowley John F | Executive Chairman | Form 4 sale | 11,346 | $128k | 1.3% | Plan not stated | SEC |
| Sep 1, 2022 | Campbell Bradley L | President & CEO | Form 4 sale | 5,470 | $62k | 0.8% | Plan not stated | SEC |
| Aug 15, 2022 | Crowley John F | Executive Chairman | Form 4 sale | 10,468 | $129k | 1.2% | Plan not stated | SEC |
| Aug 5, 2022 | Quimi Daphne | Chief Financial Officer | Form 4 sale | 5,798 | $70k | 1.7% | Plan not stated | SEC |
| Aug 5, 2022 | Clark David Michael | Chief People Officer | Form 4 sale | 11,322 | $142k | 5.0% | Plan not stated | SEC |
| Aug 1, 2022 | Rosenberg Ellen | Chief Legal Officer | Form 4 sale | 11,123 | $111k | 3.8% | Plan not stated | SEC |
| Aug 1, 2022 | Crowley John F | Executive Chairman | Form 4 sale | 11,346 | $113k | 1.3% | Plan not stated | SEC |
| Aug 1, 2022 | Campbell Bradley L | President & CEO | Form 4 sale | 5,470 | $55k | 0.8% | Plan not stated | SEC |
| Jul 15, 2022 | Crowley John F | Chairman & CEO | Form 4 sale | 10,468 | $114k | 1.1% | Plan not stated | SEC |
| Jul 1, 2022 | Crowley John F | Chairman & CEO | Form 4 sale | 11,346 | $122k | 1.2% | Plan not stated | SEC |
| Jul 1, 2022 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 5,470 | $59k | 0.8% | Plan not stated | SEC |
| Jun 21, 2022 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 16,410 | $164k | 2.3% | Plan not stated | SEC |
| Jun 21, 2022 | Rosenberg Ellen | Chief Legal Officer | Form 4 sale | 11,122 | $111k | 3.7% | Plan not stated | SEC |
| Jun 17, 2022 | Quimi Daphne | Chief Financial Officer | Form 4 sale | 4,396 | $40k | 1.3% | Plan not stated | SEC |
| Jun 15, 2022 | Crowley John F | Chairman & CEO | Form 4 sale | 10,468 | $84k | 1.1% | Plan not stated | SEC |
| Jun 3, 2022 | Crowley John F | Chairman & CEO | Form 4 sale | 11,346 | $91k | 1.2% | Plan not stated | SEC |
| May 23, 2022 | Crowley John F | Chairman & CEO | Form 4 sale | 21,814 | $175k | 2.3% | Plan not stated | SEC |
| May 2, 2022 | Mcglynn Margaret G | Director | Form 4 sale | 15,000 | $105k | 28.3% | Unusual | SEC |
| May 2, 2022 | Raab Michael | Director | Form 4 sale | 15,000 | $105k | 29.0% | Unusual | SEC |
| Apr 19, 2022 | Crowley John F | Chairman & CEO | Form 4 sale | 10,468 | $84k | 1.1% | Plan not stated | SEC |
| Apr 7, 2022 | Rosenberg Ellen | Chief Legal Officer | Form 4 sale | 11,018 | $100k | 3.5% | Plan not stated | SEC |
| Mar 18, 2022 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,940 | $109k | 1.8% | Plan not stated | SEC |
| Jan 18, 2022 | Crowley John F | Chairman & CEO | Form 4 sale | 8,564 | $88k | 0.9% | Plan not stated | SEC |
| Jan 5, 2022 | Crowley John F | Chairman & CEO | Form 4 sale | 63,543 | $774k | 8.8% | Unusual | SEC |
| Jan 3, 2022 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 5,470 | $65k | 1.3% | Plan not stated | SEC |
| Dec 22, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 3,000 | $35k | 0.7% | Plan not stated | SEC |
| Dec 1, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,515 | $116k | 2.2% | Plan not stated | SEC |
| Nov 15, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 24,935 | $293k | 2.9% | Plan not stated | SEC |
| Nov 3, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 35,558 | $417k | 4.1% | Plan not stated | SEC |
| Nov 1, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,515 | $119k | 2.2% | Plan not stated | SEC |
| Oct 15, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 22,000 | $247k | 2.6% | Plan not stated | SEC |
| Oct 1, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 7,500 | $75k | 0.9% | Plan not stated | SEC |
| Oct 1, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,515 | $105k | 2.2% | Plan not stated | SEC |
| Sep 15, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 22,000 | $244k | 2.6% | Plan not stated | SEC |
| Sep 3, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 5,238 | $63k | 0.6% | Plan not stated | SEC |
| Sep 3, 2021 | Prout Samantha | Principal Accounting Officer | Form 4 sale | 4,925 | $59k | 5.6% | Plan not stated | SEC |
| Sep 1, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,515 | $121k | 2.2% | Plan not stated | SEC |
| Sep 1, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 7,500 | $86k | 0.9% | Plan not stated | SEC |
| Aug 23, 2021 | Prout Samantha | Principal Accounting Officer | Form 4 sale | 5,045 | $55k | 5.7% | Plan not stated | SEC |
| Aug 16, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 22,000 | $226k | 2.5% | Plan not stated | SEC |
| Aug 5, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 37,000 | $371k | 4.2% | Plan not stated | SEC |
| Aug 5, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 21,028 | $211k | 4.4% | Plan not stated | SEC |
| Jul 12, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 14,885 | $139k | 1.7% | Plan not stated | SEC |
| Jun 15, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 22,000 | $226k | 2.4% | Plan not stated | SEC |
| Jun 7, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 29,500 | $295k | 3.3% | Plan not stated | SEC |
| Jun 7, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,514 | $105k | 2.2% | Plan not stated | SEC |
| May 3, 2021 | Mcglynn Margaret G | Director | Form 4 sale | 10,000 | $103k | 26.4% | Unusual | SEC |
| May 3, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 7,500 | $77k | 0.8% | Plan not stated | SEC |
| May 3, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,514 | $108k | 2.5% | Plan not stated | SEC |
| Apr 22, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 7,683 | $77k | 0.9% | Plan not stated | SEC |
| Apr 15, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 22,000 | $222k | 2.4% | Plan not stated | SEC |
| Apr 1, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,514 | $105k | 2.7% | Plan not stated | SEC |
| Apr 1, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 7,500 | $75k | 0.9% | Plan not stated | SEC |
| Mar 22, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 7,682 | $79k | 0.9% | Plan not stated | SEC |
| Mar 15, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 22,000 | $237k | 2.6% | Plan not stated | SEC |
| Mar 1, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 7,500 | $89k | 0.9% | Plan not stated | SEC |
| Mar 1, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,514 | $124k | 2.7% | Plan not stated | SEC |
| Feb 22, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 7,682 | $92k | 0.9% | Plan not stated | SEC |
| Feb 16, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 22,000 | $270k | 2.5% | Plan not stated | SEC |
| Feb 1, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 7,500 | $143k | 0.9% | Plan not stated | SEC |
| Feb 1, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,514 | $201k | 2.7% | Plan not stated | SEC |
| Jan 20, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 72,000 | $1.6M | 7.7% | Unusual | SEC |
| Jan 4, 2021 | Crowley John F | Chairman & CEO | Form 4 sale | 7,500 | $166k | 1.0% | Plan not stated | SEC |
| Jan 4, 2021 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,514 | $233k | 3.3% | Plan not stated | SEC |
| Dec 21, 2020 | Quimi Daphne | Chief Financial Officer | Form 4 sale | 5,000 | $120k | 2.0% | Plan not stated | SEC |
| Dec 15, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 22,000 | $526k | 2.6% | Plan not stated | SEC |
| Dec 14, 2020 | Do Hung | Chief Science Officer | Form 4 sale | 111,125 | $2.7M | 21.3% | Plan not stated | SEC |
| Dec 1, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 7,500 | $171k | 0.9% | Plan not stated | SEC |
| Dec 1, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 24,783 | $564k | 6.8% | Plan not stated | SEC |
| Nov 4, 2020 | Prout Samantha | Principal Accounting Officer | Form 4 sale | 5,931 | $119k | 25.7% | Unusual | SEC |
| Nov 2, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 33,875 | $605k | 3.9% | Plan not stated | SEC |
| Nov 2, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 24,782 | $443k | 6.8% | Plan not stated | SEC |
| Oct 9, 2020 | Do Hung | Chief Science Officer | Form 4 sale | 193,700 | $2.9M | 27.1% | Unusual | SEC |
| Oct 1, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 29,900 | $419k | 3.4% | Plan not stated | SEC |
| Oct 1, 2020 | Quimi Daphne | Chief Financial Officer | Form 4 sale | 5,000 | $70k | 2.4% | Plan not stated | SEC |
| Sep 30, 2020 | Barth Jay | Chief Medical Officer | Form 4 sale | 4,064 | $59k | 2.4% | Plan not stated | SEC |
| Sep 28, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 24,782 | $344k | 6.8% | Plan not stated | SEC |
| Sep 1, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 29,900 | $424k | 3.4% | Plan not stated | SEC |
| Aug 31, 2020 | Barth Jay | Chief Medical Officer | Form 4 sale | 28,750 | $424k | 15.0% | Plan not stated | SEC |
| Aug 17, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $298k | 2.3% | Plan not stated | SEC |
| Aug 5, 2020 | Prout Samantha | Principal Accounting Officer | Form 4 sale | 198 | $3k | 1.1% | Plan not stated | SEC |
| Aug 3, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 10,000 | $148k | 2.9% | Plan not stated | SEC |
| Aug 3, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 39,655 | $586k | 4.4% | Plan not stated | SEC |
| Jul 27, 2020 | Barth Jay | Chief Medical Officer | Form 4 sale | 30,000 | $452k | 15.5% | Plan not stated | SEC |
| Jul 16, 2020 | Rosenberg Ellen | Chief Legal Officer | Form 4 sale | 30,000 | $458k | 13.3% | Plan not stated | SEC |
| Jul 15, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $311k | 2.2% | Plan not stated | SEC |
| Jul 10, 2020 | Barth Jay | Chief Medical Officer | Form 4 sale | 73,290 | $1.2M | 31.0% | Unusual | SEC |
| Jul 8, 2020 | Barth Jay | Chief Medical Officer | Form 4 sale | 243,098 | $3.9M | 59.8% | Unusual | SEC |
| Jul 8, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 2,500 | $40k | 0.7% | Plan not stated | SEC |
| Jul 2, 2020 | Prout Samantha | Principal Accounting Officer | Form 4 sale | 198 | $3k | 1.1% | Plan not stated | SEC |
| Jul 1, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 12,500 | $193k | 3.6% | Plan not stated | SEC |
| Jul 1, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 39,655 | $614k | 4.3% | Plan not stated | SEC |
| Jul 1, 2020 | Quimi Daphne | Chief Financial Officer | Form 4 sale | 6,872 | $106k | 3.2% | Plan not stated | SEC |
| Jun 29, 2020 | Barth Jay | Chief Medical Officer | Form 4 sale | 30,000 | $465k | 15.5% | Plan not stated | SEC |
| Jun 19, 2020 | Prout Samantha | Principal Accounting Officer | Form 4 sale | 3,366 | $50k | 16.4% | Plan not stated | SEC |
| Jun 17, 2020 | Barth Jay | Chief Medical Officer | Form 4 sale | 1,904 | $26k | 1.2% | Plan not stated | SEC |
| Jun 16, 2020 | Prout Samantha | Principal Accounting Officer | Form 4 sale | 2,932 | $38k | 14.6% | Plan not stated | SEC |
| Jun 15, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $218k | 2.2% | Plan not stated | SEC |
| Jun 2, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 20,002 | $254k | 5.4% | Plan not stated | SEC |
| Jun 1, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 9,755 | $123k | 1.1% | Plan not stated | SEC |
| Jun 1, 2020 | Raab Michael | Director | Form 4 sale | 5,000 | $63k | 24.8% | Plan not stated | SEC |
| May 26, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 2,500 | $33k | 0.7% | Plan not stated | SEC |
| May 15, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $229k | 2.1% | Plan not stated | SEC |
| May 1, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 17,503 | $198k | 4.7% | Plan not stated | SEC |
| May 1, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 9,755 | $110k | 1.0% | Plan not stated | SEC |
| Apr 17, 2020 | Mcglynn Margaret G | Director | Form 4 sale | 10,000 | $110k | 31.2% | Unusual | SEC |
| Apr 15, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $198k | 2.1% | Plan not stated | SEC |
| Apr 7, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 2,500 | $25k | 0.7% | Plan not stated | SEC |
| Apr 1, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 9,755 | $89k | 1.1% | Plan not stated | SEC |
| Apr 1, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 15,003 | $136k | 4.1% | Plan not stated | SEC |
| Mar 20, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $180k | 2.1% | Plan not stated | SEC |
| Mar 5, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 2,500 | $25k | 0.7% | Plan not stated | SEC |
| Mar 2, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 9,755 | $89k | 1.1% | Plan not stated | SEC |
| Mar 2, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 15,003 | $136k | 4.0% | Plan not stated | SEC |
| Feb 18, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $217k | 2.1% | Plan not stated | SEC |
| Feb 12, 2020 | Clark David Michael | Chief People Officer | Form 4 sale | 7,107 | $78k | 4.6% | Plan not stated | SEC |
| Feb 12, 2020 | Do Hung | Chief Science Officer | Form 4 sale | 63,356 | $698k | 11.0% | Plan not stated | SEC |
| Feb 5, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 2,500 | $25k | 0.7% | Plan not stated | SEC |
| Feb 3, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 15,003 | $134k | 4.0% | Plan not stated | SEC |
| Feb 3, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 9,754 | $87k | 1.0% | Plan not stated | SEC |
| Jan 15, 2020 | Rosenberg Ellen | Chief Legal Officer | Form 4 sale | 22,100 | $229k | 10.7% | Plan not stated | SEC |
| Jan 15, 2020 | Barth Jay | Chief Medical Officer | Form 4 sale | 20,720 | $214k | 11.7% | Plan not stated | SEC |
| Jan 15, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 5,064 | $52k | 1.3% | Plan not stated | SEC |
| Jan 15, 2020 | Crowley John F | Chairman & CEO | Form 4 sale | 100,000 | $1M | 9.4% | Unusual | SEC |
| Jan 9, 2020 | Mcglynn Margaret G | Director | Form 4 sale | 20,000 | $200k | 47.5% | Unusual | SEC |
| Jan 9, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 2,500 | $25k | 0.7% | Plan not stated | SEC |
| Jan 9, 2020 | Quimi Daphne | Chief Financial Officer | Form 4 sale | 15,000 | $149k | 8.2% | Plan not stated | SEC |
| Jan 7, 2020 | Barth Jay | Chief Medical Officer | Form 4 sale | 16,774 | $156k | 9.7% | Plan not stated | SEC |
| Jan 2, 2020 | Barth Jay | Chief Medical Officer | Form 4 sale | 9,753 | $93k | 4.9% | Plan not stated | SEC |
| Jan 2, 2020 | Rosenberg Ellen | Chief Legal Officer | Form 4 sale | 10,448 | $100k | 4.9% | Plan not stated | SEC |
| Jan 2, 2020 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 22,127 | $212k | 5.8% | Plan not stated | SEC |
| Dec 16, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $191k | 2.6% | Plan not stated | SEC |
| Dec 2, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $208k | 2.6% | Plan not stated | SEC |
| Nov 25, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 40,000 | $400k | 5.2% | Plan not stated | SEC |
| Nov 15, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $190k | 2.6% | Plan not stated | SEC |
| Nov 8, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $180k | 2.6% | Plan not stated | SEC |
| Oct 11, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 14,500 | $116k | 1.9% | Plan not stated | SEC |
| Sep 11, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $201k | 2.6% | Plan not stated | SEC |
| Aug 1, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $251k | 2.6% | Plan not stated | SEC |
| Jul 1, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $249k | 2.6% | Plan not stated | SEC |
| Jun 3, 2019 | Raab Michael | Director | Form 4 sale | 5,000 | $56k | 36.0% | Unusual | SEC |
| Jun 3, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $223k | 2.6% | Plan not stated | SEC |
| May 1, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $270k | 2.6% | Plan not stated | SEC |
| Apr 5, 2019 | Barth Jay | Chief Medical Officer | Form 4 sale | 50,000 | $710k | 27.8% | Unusual | SEC |
| Apr 1, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $273k | 2.9% | Plan not stated | SEC |
| Mar 1, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $272k | 2.9% | Plan not stated | SEC |
| Feb 25, 2019 | Barth Jay | Chief Medical Officer | Form 4 sale | 70,000 | $876k | 35.0% | Unusual | SEC |
| Feb 1, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 20,000 | $242k | 2.9% | Plan not stated | SEC |
| Jan 22, 2019 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 36,000 | $425k | 13.1% | Plan not stated | SEC |
| Jan 16, 2019 | Do Hung | Chief Science Officer | Form 4 sale | 53,269 | $641k | 10.8% | Plan not stated | SEC |
| Jan 15, 2019 | Crowley John F | Chairman & CEO | Form 4 sale | 103,500 | $1.2M | 13.4% | Plan not stated | SEC |
| Oct 15, 2018 | Baird William D III | Chief Financial Officer | Form 4 sale | 10,000 | $122k | 7.8% | Plan not stated | SEC |
| Jul 2, 2018 | Baird William D III | Chief Financial Officer | Form 4 sale | 10,000 | $156k | 8.5% | Plan not stated | SEC |
| Jul 2, 2018 | Andrews Kurt J. | SVP, Human Resources | Form 4 sale | 5,000 | $78k | 12.4% | Plan not stated | SEC |
| Jun 1, 2018 | Do Hung | Chief Science Officer | Form 4 sale | 25,000 | $418k | 5.9% | Plan not stated | SEC |
| May 16, 2018 | Mcglynn Margaret G | Director | Form 4 sale | 10,000 | $160k | 38.7% | Unusual | SEC |
| May 16, 2018 | Do Hung | Chief Science Officer | Form 4 sale | 25,000 | $375k | 5.6% | Plan not stated | SEC |
| May 14, 2018 | Barth Jay | Chief Medical Officer | Form 4 sale | 5,000 | $70k | 5.5% | Plan not stated | SEC |
| Apr 17, 2018 | Do Hung | Chief Science Officer | Form 4 sale | 50,000 | $750k | 10.1% | Plan not stated | SEC |
| Apr 16, 2018 | Raab Michael | Director | Form 4 sale | 5,000 | $72k | 46.2% | Unusual | SEC |
| Apr 12, 2018 | Barth Jay | Chief Medical Officer | Form 4 sale | 5,000 | $74k | 5.5% | Plan not stated | SEC |
| Apr 2, 2018 | Andrews Kurt J. | SVP, Human Resources | Form 4 sale | 5,000 | $71k | 11.0% | Plan not stated | SEC |
| Apr 2, 2018 | Baird William D III | Chief Financial Officer | Form 4 sale | 10,000 | $143k | 7.8% | Plan not stated | SEC |
| Mar 12, 2018 | Barth Jay | Chief Medical Officer | Form 4 sale | 5,000 | $75k | 5.5% | Plan not stated | SEC |
| Mar 9, 2018 | Quimi Daphne | SVP, Finance | Form 4 sale | 8,750 | $131k | 12.0% | Plan not stated | SEC |
| Mar 1, 2018 | Quimi Daphne | SVP, Finance | Form 4 sale | 8,149 | $115k | 11.2% | Plan not stated | SEC |
| Jan 23, 2018 | Barth Jay | Chief Medical Officer | Form 4 sale | 20,000 | $336k | 19.0% | Plan not stated | SEC |
| Jan 22, 2018 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 32,500 | $517k | 17.4% | Plan not stated | SEC |
| Jan 2, 2018 | Raab Michael | Director | Form 4 sale | 9,366 | $140k | 61.7% | Unusual | SEC |
| Jan 2, 2018 | Andrews Kurt J. | SVP, Human Resources | Form 4 sale | 10,000 | $147k | 22.4% | Plan not stated | SEC |
| Jan 2, 2018 | Barth Jay | Chief Medical Officer | Form 4 sale | 5,000 | $74k | 7.2% | Plan not stated | SEC |
| Jan 2, 2018 | Baird William D III | Chief Financial Officer | Form 4 sale | 10,000 | $147k | 9.5% | Plan not stated | SEC |
| Jan 2, 2018 | Quimi Daphne | SVP, Finance | Form 4 sale | 8,000 | $118k | 12.8% | Plan not stated | SEC |
| Jan 2, 2018 | Hayden Donald J Jr | Director | Form 4 sale | 20,000 | $300k | 77.5% | Unusual | SEC |
| Dec 29, 2017 | Crowley John F | Chairman & CEO | Form 4 sale | 18,970 | $280k | 5.5% | Plan not stated | SEC |
| Dec 21, 2017 | Crowley John F | Chairman & CEO | Form 4 sale | 65,581 | $886k | 16.7% | Plan not stated | SEC |
| Dec 11, 2017 | Crowley John F | Chairman & CEO | Form 4 sale | 12,206 | $165k | 3.6% | Plan not stated | SEC |
| Dec 4, 2017 | Crowley John F | Chairman & CEO | Form 4 sale | 47,213 | $643k | 12.6% | Plan not stated | SEC |
| Dec 1, 2017 | Barth Jay | Chief Medical Officer | Form 4 sale | 5,000 | $68k | 7.2% | Plan not stated | SEC |
| Oct 18, 2017 | Crowley John F | Chairman & CEO | Form 4 sale | 71,735 | $1.1M | 17.9% | Plan not stated | SEC |
| Oct 16, 2017 | Crowley John F | Chairman & CEO | Form 4 sale | 449,295 | $6.4M | 57.8% | Unusual | SEC |
| Oct 12, 2017 | Baird William D III | Chief Financial Officer | Form 4 sale | 40,000 | $570k | 29.6% | Unusual | SEC |
| Oct 12, 2017 | Barth Jay | Chief Medical Officer | Form 4 sale | 5,000 | $71k | 7.2% | Plan not stated | SEC |
| Oct 12, 2017 | Do Hung | Chief Science Officer | Form 4 sale | 50,194 | $715k | 9.6% | Plan not stated | SEC |
| Oct 12, 2017 | Raab Michael | Director | Form 4 sale | 10,000 | $143k | 63.2% | Unusual | SEC |
| Oct 12, 2017 | Quimi Daphne | SVP, Finance | Form 4 sale | 7,000 | $100k | 11.3% | Plan not stated | SEC |
| Jun 19, 2017 | Barth Jay | Chief Medical Officer | Form 4 sale | 30,000 | $300k | 31.9% | Unusual | SEC |
| May 19, 2017 | Do Hung | Chief Science Officer | Form 4 sale | 29,914 | $239k | 5.9% | Plan not stated | SEC |
| May 15, 2017 | Do Hung | Chief Science Officer | Form 4 sale | 29,914 | $239k | 5.6% | Plan not stated | SEC |
| Mar 2, 2017 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 49,050 | $392k | 27.8% | Unusual | SEC |
| Feb 7, 2017 | Do Hung | Chief Science Officer | Form 4 sale | 25,000 | $150k | 4.5% | Plan not stated | SEC |
| Jan 13, 2017 | Do Hung | Chief Science Officer | Form 4 sale | 25,000 | $150k | 4.3% | Plan not stated | SEC |
| Nov 9, 2016 | Quimi Daphne | SVP, Finance | Form 4 sale | 8,546 | $68k | 26.1% | Unusual | SEC |
| Nov 1, 2016 | Do Hung | Chief Science Officer | Form 4 sale | 25,000 | $175k | 4.5% | Plan not stated | SEC |
| Oct 3, 2016 | Do Hung | Chief Science Officer | Form 4 sale | 25,000 | $181k | 4.3% | Plan not stated | SEC |
| Sep 20, 2016 | Baird William D III | Chief Financial Officer | Form 4 sale | 20,500 | $164k | 36.3% | Unusual | SEC |
| Sep 6, 2016 | Do Hung | Chief Science Officer | Form 4 sale | 25,000 | $175k | 4.1% | Plan not stated | SEC |
| Aug 25, 2016 | Perceptive Advisors LLC | Other | Form 4 sale | 1.1M | $7.5M | 7.2% | Plan not stated | SEC |
| Aug 4, 2016 | Do Hung | Chief Science Officer | Form 4 sale | 25,000 | $175k | 3.9% | Plan not stated | SEC |
| Aug 4, 2016 | Barth Jay | Chief Medical Officer | Form 4 sale | 10,458 | $73k | 41.1% | Unusual | SEC |
| Jul 27, 2016 | Barth Jay | Chief Medical Officer | Form 4 sale | 20,916 | $146k | 45.1% | Unusual | SEC |
| Oct 1, 2015 | Quimi Daphne | Vice President Finance | Form 4 sale | 11,250 | $148k | 66.4% | Unusual | SEC |
| Oct 1, 2015 | Peist Kenneth | VP, Legal & IP | Form 4 sale | 10,000 | $131k | 75.8% | Unusual | SEC |
| Sep 21, 2015 | Baird William D III | Chief Financial Officer | Form 4 sale | 15,236 | $256k | 21.2% | Plan not stated | SEC |
| Sep 21, 2015 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 13,001 | $218k | 7.7% | Plan not stated | SEC |
| Sep 15, 2015 | Do Hung | Chief Science Officer | Form 4 sale | 25,000 | $444k | 3.4% | Plan not stated | SEC |
| Sep 14, 2015 | Quimi Daphne | Vice President Finance | Form 4 sale | 2,500 | $45k | 30.5% | Unusual | SEC |
| Jul 16, 2015 | Crowley John F | Chairman & CEO | Form 4 sale | 16,025 | $256k | 16.1% | Plan not stated | SEC |
| Jul 14, 2015 | Crowley John F | Chairman & CEO | Form 4 sale | 150,000 | $2.3M | 64.2% | Unusual | SEC |
| Jul 13, 2015 | Valenzano Ken | SVP, Pharmacology & Biology | Form 4 sale | 15,000 | $225k | 35.1% | Unusual | SEC |
| Jul 13, 2015 | Sblendorio Glenn | Director | Form 4 sale | 10,000 | $150k | 45.6% | Unusual | SEC |
| Jul 8, 2015 | Doshi Dipal | SVP Strategy & Bus Dev | Form 4 sale | 6,250 | $87k | 78.6% | Unusual | SEC |
| Jul 1, 2015 | Quimi Daphne | Vice President Finance | Form 4 sale | 2,600 | $36k | 24.1% | Plan not stated | SEC |
| Jul 1, 2015 | Peist Kenneth | VP, Legal & IP | Form 4 sale | 10,000 | $140k | 75.8% | Unusual | SEC |
| Jul 1, 2015 | Gershkowitz Jayne | SVP, Chief Patient Advocate | Form 4 sale | 10,649 | $149k | 65.2% | Unusual | SEC |
| Jun 23, 2015 | Hayden Donald J Jr | Director | Form 4 sale | 55,000 | $771k | 100.0% | Unusual | SEC |
| Jun 22, 2015 | Valenzano Ken | SVP, Pharmacology & Biology | Form 4 sale | 20,500 | $284k | 42.5% | Unusual | SEC |
| Jun 22, 2015 | Castelli Jeff | SVP, Program Management | Form 4 sale | 18,981 | $265k | 43.2% | Unusual | SEC |
| Jun 19, 2015 | Dilone Enrique | SVP, Technical Operations | Form 4 sale | 14,045 | $186k | 31.4% | Unusual | SEC |
| Jun 19, 2015 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 13,000 | $172k | 7.7% | Plan not stated | SEC |
| Jun 19, 2015 | Baird William D III | Chief Financial Officer | Form 4 sale | 15,235 | $202k | 21.2% | Plan not stated | SEC |
| Jun 15, 2015 | Yu Julie | VP Clinical Ops & Data Mgmt | Form 4 sale | 8,195 | $116k | 100.0% | Unusual | SEC |
| Jun 15, 2015 | Castelli Jeff | SVP, Program Management | Form 4 sale | 7,377 | $105k | 100.0% | Unusual | SEC |
| Jun 8, 2015 | Crowley John F | Chairman & CEO | Form 4 sale | 55,000 | $716k | 39.7% | Unusual | SEC |
| Jun 8, 2015 | Castelli Jeff | SVP, Program Management | Form 4 sale | 17,312 | $223k | 40.9% | Unusual | SEC |
| May 11, 2015 | Valenzano Ken | SVP, Pharmacology & Biology | Form 4 sale | 13,000 | $141k | 82.9% | Unusual | SEC |
| May 11, 2015 | Yu Julie | VP Clinical Ops & Data Mgmt | Form 4 sale | 7,500 | $81k | 47.8% | Unusual | SEC |
| May 11, 2015 | Quimi Daphne | VP Finance and Controller | Form 4 sale | 7,500 | $81k | 47.8% | Unusual | SEC |
| May 11, 2015 | Peist Kenneth | VP, Legal & IP | Form 4 sale | 12,500 | $136k | 79.7% | Unusual | SEC |
| May 11, 2015 | Kirk John | VP, Regulatory Affairs | Form 4 sale | 10,000 | $108k | 63.7% | Unusual | SEC |
| May 11, 2015 | Gershkowitz Jayne | SVP, Chief Patient Advocate | Form 4 sale | 10,000 | $108k | 63.7% | Unusual | SEC |
| May 11, 2015 | Dilone Enrique | SVP, Technical Operations | Form 4 sale | 10,000 | $109k | 63.7% | Unusual | SEC |
| May 11, 2015 | Castelli Jeff | SVP, Program Management | Form 4 sale | 10,000 | $108k | 57.5% | Unusual | SEC |
| May 11, 2015 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 24,800 | $269k | 79.0% | Unusual | SEC |
| May 11, 2015 | Baird William D III | Chief Financial Officer | Form 4 sale | 24,800 | $269k | 79.0% | Unusual | SEC |
| Apr 15, 2015 | Valenzano Ken | VP, Pharmacology & Biology | Form 4 sale | 5,000 | $63k | 9.1% | Plan not stated | SEC |
| Apr 15, 2015 | Sblendorio Glenn | Director | Form 4 sale | 20,000 | $250k | 62.6% | Unusual | SEC |
| Apr 10, 2015 | Crowley John F | Chairman & CEO | Form 4 sale | 11,678 | $140k | 12.3% | Plan not stated | SEC |
| Apr 1, 2015 | Castelli Jeff | VP, Program Management | Form 4 sale | 9,489 | $101k | 16.0% | Plan not stated | SEC |
| Mar 20, 2015 | Valenzano Ken | VP, Pharmacology & Biology | Form 4 sale | 7,751 | $91k | 13.4% | Plan not stated | SEC |
| Mar 20, 2015 | Yu Julie | VP Clinical Ops & Data Mgmt | Form 4 sale | 7,785 | $90k | 13.5% | Plan not stated | SEC |
| Mar 20, 2015 | Valenzano Ken | VP, Pharmacology & Biology | Form 4 sale | 13,050 | $150k | 20.7% | Plan not stated | SEC |
| Mar 20, 2015 | Peist Kenneth | VP, Legal & IP | Form 4 sale | 10,000 | $115k | 16.7% | Plan not stated | SEC |
| Mar 20, 2015 | Kirk John | VP, Regulatory Affairs | Form 4 sale | 10,110 | $116k | 16.8% | Plan not stated | SEC |
| Mar 20, 2015 | Gershkowitz Jayne | VP, Patient Advocacy | Form 4 sale | 10,648 | $123k | 17.6% | Plan not stated | SEC |
| Mar 20, 2015 | Dilone Enrique | VP, Technical Operations | Form 4 sale | 14,045 | $162k | 21.9% | Plan not stated | SEC |
| Mar 20, 2015 | Crowley John F | Chairman & CEO | Form 4 sale | 268,322 | $3.1M | 76.3% | Unusual | SEC |
| Mar 20, 2015 | Campbell Bradley L | Chief Operating Officer | Form 4 sale | 12,999 | $150k | 6.1% | Plan not stated | SEC |